| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |